Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus.

PubWeight™: 1.37‹?› | Rank: Top 10%

🔗 View Article (PMID 16173795)

Published in Bioconjug Chem on September 21, 2005

Authors

Jesus M de la Fuente1, Catherine C Berry

Author Affiliations

1: Centre for Cell Engineering, Institute of Biomedical and Life Science, Joseph Black Building, University of Glasgow, Glasgow G12 8QQ, UK. lafuente@iiq.csic.es

Articles citing this

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging. Part Fibre Toxicol (2010) 1.89

Systematic evaluation of nanomaterial toxicity: utility of standardized materials and rapid assays. ACS Nano (2011) 1.37

Nanoparticles for applications in cellular imaging. Nanoscale Res Lett (2007) 1.34

Self-assembled quantum dot-peptide bioconjugates for selective intracellular delivery. Bioconjug Chem (2006) 1.34

Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin Drug Deliv (2010) 1.32

Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell Mol Life Sci (2009) 1.31

Gold nanoparticles delivery in mammalian live cells: a critical review. Nano Rev (2010) 1.25

Continuous imaging of plasmon rulers in live cells reveals early-stage caspase-3 activation at the single-molecule level. Proc Natl Acad Sci U S A (2009) 1.25

Gold nanoparticles: From nanomedicine to nanosensing. Nanotechnol Sci Appl (2008) 1.21

Off to the organelles - killing cancer cells with targeted gold nanoparticles. Theranostics (2015) 1.04

Development of viral nanoparticles for efficient intracellular delivery. Nanoscale (2012) 0.99

Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine. Front Chem (2014) 0.97

Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. Adv Drug Deliv Rev (2013) 0.97

Organelle targeting: third level of drug targeting. Drug Des Devel Ther (2013) 0.97

Glucose-coated gold nanoparticles transfer across human brain endothelium and enter astrocytes in vitro. PLoS One (2013) 0.93

Monodisperse magnetite nanoparticles coupled with nuclear localization signal peptide for cell-nucleus targeting. Chem Asian J (2008) 0.93

Optimization of PAMAM-gold nanoparticle conjugation for gene therapy. Biomaterials (2013) 0.90

Cell-penetrating peptides: achievements and challenges in application for cancer treatment. J Biomed Mater Res A (2013) 0.90

Intracellular SERS nanoprobes for distinction of different neuronal cell types. Nano Lett (2013) 0.87

Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells. Mol Pharm (2011) 0.86

Internalization of C60 fullerenes into cancer cells with accumulation in the nucleus via the nuclear pore complex. Biomaterials (2012) 0.85

The potential of nanomedicine therapies to treat neovascular disease in the retina. J Angiogenes Res (2010) 0.84

Cellular uptake of gold nanoparticles directly cross-linked with carrier peptides by osteosarcoma cells. J Mater Sci Mater Med (2008) 0.83

TAT and HA2 facilitate cellular uptake of gold nanoparticles but do not lead to cytosolic localisation. PLoS One (2015) 0.83

Cell-penetrating peptide enhanced intracellular Raman imaging and photodynamic therapy. Mol Pharm (2013) 0.83

Gold nanoprobes for theranostics. Nanomedicine (Lond) (2011) 0.82

Synthesis, characterization, and direct intracellular imaging of ultrasmall and uniform glutathione-coated gold nanoparticles. Small (2012) 0.81

Effects of TAT-conjugated platinum nanoparticles on lifespan of mitochondrial electron transport complex I-deficient Caenorhabditis elegans, nuo-1. Int J Nanomedicine (2010) 0.80

Surface presentation of functional peptides in solution determines cell internalization efficiency of TAT conjugated nanoparticles. Nano Lett (2014) 0.79

Shining light on nuclear-targeted therapy using gold nanostar constructs. Ther Deliv (2012) 0.79

Pharmaceutical nanocarrier association with chondrocytes and cartilage explants: influence of surface modification and extracellular matrix depletion. Osteoarthritis Cartilage (2012) 0.79

Design and synthesis of novel histone deacetylase inhibitor derived from nuclear localization signal peptide. Bioorg Med Chem Lett (2009) 0.79

Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma. Int J Nanomedicine (2016) 0.79

Molecular characterization of full-length Tat in HIV-1 subtypes B and C. Bioinformation (2015) 0.78

Strategies on the nuclear-targeted delivery of genes. J Drug Target (2013) 0.78

In vitro evaluation of anticancer and antibacterial activities of cobalt oxide nanoparticles. J Biol Inorg Chem (2015) 0.77

Modifications of natural peptides for nanoparticle and drug design. Adv Protein Chem Struct Biol (2015) 0.77

Dendritic Guanidines as Efficient Analogues of Cell Penetrating Peptides. Pharmaceuticals (Basel) (2010) 0.77

Tracking mesenchymal stromal cells using an ultra-bright TAT-functionalized plasmonic-active nanoplatform. J Biophotonics (2015) 0.76

Enhancing the Cellular Delivery of Nanoparticles using Lipo-Oligoarginine Peptides. Adv Funct Mater (2012) 0.75

CPP-Assisted Intracellular Drug Delivery, What Is Next? Int J Mol Sci (2016) 0.75

Gold nanoparticles to improve HIV drug delivery. Future Med Chem (2015) 0.75

Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles. Int J Nanomedicine (2012) 0.75

Targeted iron oxide nanoparticles for the enhancement of radiation therapy. Biomaterials (2016) 0.75